FDA Brief

Warning letters Drugs

FDA warning letter to

AMBI Enterprises LLC

High riskIssued Apr 13, 2022Posted Apr 19, 2022Center for Drug Evaluation and Research | CDER

AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.

What happened

FDA reviewed AMBI’s product labels and its website, where the two fade creams were offered for purchase; the letter does not describe an inspection. FDA found claims that the products are skin bleaching agents containing 2% hydroquinone and that they fade dark spots. FDA says no approved new drug application is in effect, so the products are unapproved and misbranded (unlawfully labeled or marketed).

What FDA found

  1. The two fade creams are new drugs sold without an FDA-approved new drug application.

    section 505(a) of the FD&C Act, 21 U.S.C. 355(a)
  2. The products are misbranded because they are nonprescription drugs not covered by an approved application and do not meet section 505G requirements.

    section 502(ee) of the FD&C Act, 21 U.S.C. 352(ee)
  3. FDA treats skin bleaching drugs containing hydroquinone as not generally recognized as safe and effective under its proposed rule, so they are deemed new drugs.

    section 505G(a)(4) of the FD&C Act, 21 U.S.C. 355h(a)(4)
  4. Introducing these products into interstate commerce is prohibited.

    sections 301(d) and 301(a) of the FD&C Act, 21 U.S.C. 331(d) and 331(a)

What FDA wants

FDA tells AMBI to investigate and correct the violations, prevent recurrence, and respond in writing within 15 working days with actions taken or reasoning and a completion schedule if more time is needed.

Who should pay attention

  • retailers and websites selling AMBI fade creams
  • brands selling hydroquinone skin-bleaching products
  • companies marketing OTC drugs without an approved application

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Jing Cheong Asia Inc. dba New York Tong Ren Tang

    New York Tong Ren Tang marketed unapproved new drugs, including eye drops, on its website.

    High risk